These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 14611699

  • 1. Thyrotropin receptor-DNA vaccination of transgenic mice expressing HLA-DR3 or HLA-DQ6b.
    Pichurin P, Chen CR, Pichurina O, David C, Rapoport B, McLachlan SM.
    Thyroid; 2003 Oct; 13(10):911-7. PubMed ID: 14611699
    [Abstract] [Full Text] [Related]

  • 2. HLA-DR3 transgenic mice immunized with adenovirus encoding the thyrotropin receptor: T cell epitopes and functional analysis of the CD40 Graves' polymorphism.
    Pichurin P, Pham N, David CS, Rapoport B, McLachlan SM.
    Thyroid; 2006 Dec; 16(12):1221-7. PubMed ID: 17199432
    [Abstract] [Full Text] [Related]

  • 3. Thyrotropin Receptor-Specific Lymphocytes in Adenovirus-TSHR-Immunized Native and Human Leukocyte Antigen-DR3-Transgenic Mice and in Graves' Disease Patient Blood.
    Degen H, Gavvovidis I, Blankenstein T, Uhland K, Ungerer M.
    Thyroid; 2021 Jun; 31(6):950-963. PubMed ID: 33208049
    [Abstract] [Full Text] [Related]

  • 4. Graves' hyperthyroidism and thyroiditis in HLA-DRB1*0301 (DR3) transgenic mice after immunization with thyrotropin receptor DNA.
    Flynn JC, Rao PV, Gora M, Alsharabi G, Wei W, Giraldo AA, David CS, Banga JP, Kong YM.
    Clin Exp Immunol; 2004 Jan; 135(1):35-40. PubMed ID: 14678262
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. "Hijacking" the thyrotropin receptor: A chimeric receptor-lysosome associated membrane protein enhances deoxyribonucleic acid vaccination and induces Graves' hyperthyroidism.
    Pichurin PN, Chazenbalk GD, Aliesky H, Pichurina O, Rapoport B, McLachlan SM.
    Endocrinology; 2004 Dec; 145(12):5504-14. PubMed ID: 15331574
    [Abstract] [Full Text] [Related]

  • 7. Characterization of HLA DR3/DQ2 transgenic mice: a potential humanized animal model for autoimmune disease studies.
    Chen D, Ueda R, Harding F, Patil N, Mao Y, Kurahara C, Platenburg G, Huang M.
    Eur J Immunol; 2003 Jan; 33(1):172-82. PubMed ID: 12594846
    [Abstract] [Full Text] [Related]

  • 8. Epitope recognition in HLA-DR3 transgenic mice immunized to TSH-R protein or peptides.
    Inaba H, Moise L, Martin W, De Groot AS, Desrosiers J, Tassone R, Buchman G, Akamizu T, De Groot LJ.
    Endocrinology; 2013 Jun; 154(6):2234-43. PubMed ID: 23592747
    [Abstract] [Full Text] [Related]

  • 9. Expression of IFNalpha-inducible genes and modulation of HLA-DR and thyroid stimulating hormone receptors in Graves' disease.
    Kuang M, Wang S, Wu M, Ning G, Yao Z, Li L.
    Mol Cell Endocrinol; 2010 May 05; 319(1-2):23-9. PubMed ID: 20015465
    [Abstract] [Full Text] [Related]

  • 10. Dynamics of thyroid-stimulating and -blocking antibodies to the thyrotropin receptor in a murine model of Graves' disease.
    Muehlberg T, Gilbert JA, Rao PV, McGregor AM, Banga JP.
    Endocrinology; 2004 Apr 05; 145(4):1539-45. PubMed ID: 14764633
    [Abstract] [Full Text] [Related]

  • 11. A Mouse Thyrotropin Receptor A-Subunit Transgene Expressed in Thyroiditis-Prone Mice May Provide Insight into Why Graves' Disease Only Occurs in Humans.
    McLachlan SM, Aliesky HA, Rapoport B.
    Thyroid; 2019 Aug 05; 29(8):1138-1146. PubMed ID: 31184281
    [Abstract] [Full Text] [Related]

  • 12. Insight into Graves' hyperthyroidism from animal models.
    McLachlan SM, Nagayama Y, Rapoport B.
    Endocr Rev; 2005 Oct 05; 26(6):800-32. PubMed ID: 15827111
    [Abstract] [Full Text] [Related]

  • 13. Contrasting activities of thyrotropin receptor antibodies in experimental models of Graves' disease induced by injection of transfected fibroblasts or deoxyribonucleic acid vaccination.
    Rao PV, Watson PF, Weetman AP, Carayanniotis G, Banga JP.
    Endocrinology; 2003 Jan 05; 144(1):260-6. PubMed ID: 12488353
    [Abstract] [Full Text] [Related]

  • 14. Genetic immunization with mouse thyrotrophin hormone receptor plasmid breaks self-tolerance for a murine model of autoimmune thyroid disease and Graves' orbitopathy.
    Schlüter A, Horstmann M, Diaz-Cano S, Plöhn S, Stähr K, Mattheis S, Oeverhaus M, Lang S, Flögel U, Berchner-Pfannschmidt U, Eckstein A, Banga JP.
    Clin Exp Immunol; 2018 Mar 05; 191(3):255-267. PubMed ID: 29058307
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. TSH receptor-adenovirus-induced Graves' hyperthyroidism is attenuated in both interferon-gamma and interleukin-4 knockout mice; implications for the Th1/Th2 paradigm.
    Nagayama Y, Saitoh O, McLachlan SM, Rapoport B, Kano H, Kumazawa Y.
    Clin Exp Immunol; 2004 Dec 05; 138(3):417-22. PubMed ID: 15544617
    [Abstract] [Full Text] [Related]

  • 17. Binding of human thyrotropin receptor peptides to a Graves' disease-predisposing human leukocyte antigen class II molecule.
    Sawai Y, DeGroot LJ.
    J Clin Endocrinol Metab; 2000 Mar 05; 85(3):1176-9. PubMed ID: 10720058
    [Abstract] [Full Text] [Related]

  • 18. A transgenic mouse that spontaneously develops pathogenic TSH receptor antibodies will facilitate study of antigen-specific immunotherapy for human Graves' disease.
    McLachlan SM, Rapoport B.
    Endocrine; 2019 Nov 05; 66(2):137-148. PubMed ID: 31560118
    [Abstract] [Full Text] [Related]

  • 19. Induction of hyperthyroidism in mice by intradermal immunization with DNA encoding the thyrotropin receptor.
    Barrett K, Liakata E, Rao PV, Watson PF, Weetman AP, Lymberi P, Banga JP, Carayanniotis G.
    Clin Exp Immunol; 2004 Jun 05; 136(3):413-22. PubMed ID: 15147342
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.